ALDH1A1 and breast cancer: ALDH1- CD44+ Ki67- CSCs, shown within mammary tumors and located in a peripheral position, at the invasive front, would be presumable CSC3s, constituting about 12.87% of the tumor mass (Liu et al., 2014).